SynthesisInfection2026
Marine sources as a treasure trove of antimicrobial agents: a systematic review.
Synthesis in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis review aims to discuss various marine antimicrobial sources, their bioactive agents, and their therapeutic applications and antimicrobial potential.
methodsFor this study, the relevant published research articles were meticulously searched and collected from PubMed, Science Direct, Science Open, DOAJ, Google Scholar, Research Gate, and Scilit.net. Only English-language works published between 2015 and February 2025 were included in the literature search. Data collection focused on the marine antimicrobial compounds, which were reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) approach.
resultsThis review finds excellent antimicrobial potentials of various bioactive compounds isolated from diverse marine sources. For instance, Callyspongia diffusa a demospongiae which chloroform & ethyl acetate extract is very promising against bacteria K. pneumoniae, E. coli, and E. faecalis (MIC range: 0.0002-0.0004 mg/ml) and against fungi C. albicans (MIC: 0.0002-0.0008 mg/ml) and A. niger (MIC: 0.0002-0.0004 mg/ml). Antiviral marine source Nizamuddinia zanardinii brown algae which aqueous extract is very potent against HSV-2 (IC
conclusionThe findings of this review highlight the significant antimicrobial potential of marine-derived organisms as valuable sources of bioactive compounds exhibiting antibacterial, antiviral, antiprotozoal, and antifungal activities. Overall, continued exploration of marine biodiversity and systematic characterization of marine-derived compounds may contribute to the development of novel and effective antimicrobial agents in the future.
Indexed as
Identifiers
41840306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.